致力于药物研发关键试剂的生产

15801534258
info@nebulabio.cn
产品名称 NebuSelect™ Recombinant Biotinylated Human LILRA1/CD85i/LIR-6, Avi-His-tag
目录号 NBL-242354
别名 LILRA1/CD85i/LIR-6; CD85i; LILRA1; LIR6; LIR-6; LIR6MGC126563
外观 see COA
分子量 Pro17-Asn461
CAS N/A
溶解度 Water Soluble
存储条件 Short term 4℃; Long term -20℃.
保存时间 2 years
备注1 O75019-1
备注2
目录号 规格 价格 库存状态  
NBL-242354-100ug 100ug Inquire Inquire
NBL-242354-1mg 1mg Inquire Inquire
NBL-242354-Customized Size N/A Inquire Inquire


Product Name:

NebuSelect™ Recombinant Biotinylated Human LILRA1/CD85i/LIR-6, Avi-His-tag


Catalog#:

NBL-242354


Description:

NebuSelect™ Recombinant Biotinylated Human LILRA1/CD85i/LIR-6, Avi-His-tag(Cat#NBL-242354) is expressed in HEK293 with His tag and Avi tag at the C-Terminus.It contains Pro17-Asn461.


Species:

Human


Expression System:

HEK293


Molecular Weight: 

The protein has a predicted MW of 51.4 kDa. Due to glycosylation, the protein migrates to 70-80 kDa based on Bis-Tris PAGE result.


Target Name:

LILRA1/CD85i/LIR-6; CD85i; LILRA1; LIR6; LIR-6; LIR6MGC126563


Target Information:

LILRA1, also known as CD85i and LIR-6, is an approximately 70 kDa variably glycosylated transmembrane protein that regulates immune cell activation. Mature human LILRA1 consists of a 445 amino acid (aa) extracellular domain (ECD) with 4 Ig-like domains, a 21 aa transmembrane segment, and a 7 aa cytoplasmic tail. LILRA1 may act as receptor for class I MHC antigens.


Amino Acid Sequence: 

Pro17-Asn461


Purity:

>95%


Formulation:

see COA


Endotoxin:

<1EU/ug(LAL Method)


Storage: 

4°C for short term. 

-20°C for long term.


To get more information, please contact us freely.

相关产品